Syntrix Biosystems, Inc.
Clinical trials sponsored by Syntrix Biosystems, Inc., explained in plain language.
-
New Two-Drug attack on tough prostate cancer
Disease control Recruiting nowThis study is testing whether adding an experimental drug called SX-682 to a standard prostate cancer drug (enzalutamide) can help men whose cancer has spread and stopped responding to other hormone therapies. The goal is to see if this combination can control the cancer's growth…
Phase: PHASE2 • Sponsor: Syntrix Biosystems, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug trial seeks to control rare blood cancer
Disease control Recruiting nowThis early-stage study aims to find a safe and effective dose of an experimental drug called SX-682 for patients with myelodysplastic syndrome (MDS), a type of blood cancer. Researchers will test SX-682 alone and combined with another drug, decitabine, in up to 151 adults whose p…
Phase: PHASE1 • Sponsor: Syntrix Biosystems, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC